GSK receives positive opinion from European CHMP for pazopanib in the treatment of patients with certain advanced soft tissue ...
Issued: Friday 25 May 2012, London UK GlaxoSmithKline. plc (GSK) announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending marketing authorisation for …